Vaxart, Inc. announced a change in management. Effective immediately Andrei Floroiu, President and Chief Executive Officer of Vaxart, has announced his resignation from his positions with Vaxart as President and Director on Vaxart?s Board of Directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9588 USD | -6.00% | +36.00% | +67.39% |
May. 13 | Transcript : Vaxart, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.39% | 170M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- VXRT Stock
- News Vaxart, Inc.
- Vaxart, Inc. Announces Resignation of Andrei Floroiu as President and Director